vs

Side-by-side financial comparison of OUTFRONT Media Inc. (OUT) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $513.3M, roughly 1.9× OUTFRONT Media Inc.). OUTFRONT Media Inc. runs the higher net margin — 18.9% vs -15.2%, a 34.1% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs 4.1%). OUTFRONT Media Inc. produced more free cash flow last quarter ($93.3M vs $60.0M). Over the past eight quarters, OUTFRONT Media Inc.'s revenue compounded faster (12.1% CAGR vs 0.4%).

Outfront Media, Inc. is an American advertising company. It operates in the United States. The Americas division is led by chief executive officer Nick Brien. Outfront Media has both billboards and transit displays.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

OUT vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.9× larger
XRAY
$961.0M
$513.3M
OUT
Growing faster (revenue YoY)
XRAY
XRAY
+2.1% gap
XRAY
6.2%
4.1%
OUT
Higher net margin
OUT
OUT
34.1% more per $
OUT
18.9%
-15.2%
XRAY
More free cash flow
OUT
OUT
$33.3M more FCF
OUT
$93.3M
$60.0M
XRAY
Faster 2-yr revenue CAGR
OUT
OUT
Annualised
OUT
12.1%
0.4%
XRAY

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OUT
OUT
XRAY
XRAY
Revenue
$513.3M
$961.0M
Net Profit
$96.8M
$-146.0M
Gross Margin
46.1%
Operating Margin
26.0%
-14.5%
Net Margin
18.9%
-15.2%
Revenue YoY
4.1%
6.2%
Net Profit YoY
30.8%
66.0%
EPS (diluted)
$0.57
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OUT
OUT
XRAY
XRAY
Q4 25
$513.3M
$961.0M
Q3 25
$467.5M
$904.0M
Q2 25
$460.2M
$936.0M
Q1 25
$390.7M
$879.0M
Q4 24
$493.2M
$905.0M
Q3 24
$451.9M
$951.0M
Q2 24
$477.3M
$984.0M
Q1 24
$408.5M
$953.0M
Net Profit
OUT
OUT
XRAY
XRAY
Q4 25
$96.8M
$-146.0M
Q3 25
$51.3M
$-427.0M
Q2 25
$19.5M
$-45.0M
Q1 25
$-20.6M
$20.0M
Q4 24
$74.0M
$-430.0M
Q3 24
$34.6M
$-494.0M
Q2 24
$176.8M
$-4.0M
Q1 24
$-27.2M
$18.0M
Gross Margin
OUT
OUT
XRAY
XRAY
Q4 25
46.1%
Q3 25
48.8%
Q2 25
52.4%
Q1 25
53.0%
Q4 24
49.3%
Q3 24
52.1%
Q2 24
51.9%
Q1 24
53.1%
Operating Margin
OUT
OUT
XRAY
XRAY
Q4 25
26.0%
-14.5%
Q3 25
19.2%
-24.1%
Q2 25
12.2%
-13.7%
Q1 25
3.6%
7.2%
Q4 24
22.5%
-56.2%
Q3 24
15.8%
-48.6%
Q2 24
48.0%
5.1%
Q1 24
3.4%
4.4%
Net Margin
OUT
OUT
XRAY
XRAY
Q4 25
18.9%
-15.2%
Q3 25
11.0%
-47.2%
Q2 25
4.2%
-4.8%
Q1 25
-5.3%
2.3%
Q4 24
15.0%
-47.5%
Q3 24
7.7%
-51.9%
Q2 24
37.0%
-0.4%
Q1 24
-6.7%
1.9%
EPS (diluted)
OUT
OUT
XRAY
XRAY
Q4 25
$0.57
$-0.74
Q3 25
$0.29
$-2.14
Q2 25
$0.10
$-0.22
Q1 25
$-0.14
$0.10
Q4 24
$0.49
$-2.09
Q3 24
$0.19
$-2.46
Q2 24
$1.01
$-0.02
Q1 24
$-0.18
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OUT
OUT
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$99.9M
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$710.4M
$1.3B
Total Assets
$5.3B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OUT
OUT
XRAY
XRAY
Q4 25
$99.9M
$326.0M
Q3 25
$63.0M
$363.0M
Q2 25
$28.5M
$359.0M
Q1 25
$30.5M
$398.0M
Q4 24
$46.9M
$272.0M
Q3 24
$28.0M
$296.0M
Q2 24
$49.6M
$279.0M
Q1 24
$42.4M
$291.0M
Total Debt
OUT
OUT
XRAY
XRAY
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
OUT
OUT
XRAY
XRAY
Q4 25
$710.4M
$1.3B
Q3 25
$542.6M
$1.5B
Q2 25
$539.1M
$2.0B
Q1 25
$566.9M
$2.0B
Q4 24
$649.0M
$1.9B
Q3 24
$618.2M
$2.5B
Q2 24
$664.9M
$3.1B
Q1 24
$524.2M
$3.3B
Total Assets
OUT
OUT
XRAY
XRAY
Q4 25
$5.3B
$5.4B
Q3 25
$5.2B
$5.7B
Q2 25
$5.1B
$6.1B
Q1 25
$5.1B
$6.0B
Q4 24
$5.2B
$5.8B
Q3 24
$5.2B
$6.6B
Q2 24
$5.3B
$6.9B
Q1 24
$5.5B
$7.1B
Debt / Equity
OUT
OUT
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OUT
OUT
XRAY
XRAY
Operating Cash FlowLast quarter
$118.1M
$101.0M
Free Cash FlowOCF − Capex
$93.3M
$60.0M
FCF MarginFCF / Revenue
18.2%
6.2%
Capex IntensityCapex / Revenue
4.8%
4.3%
Cash ConversionOCF / Net Profit
1.22×
TTM Free Cash FlowTrailing 4 quarters
$218.8M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OUT
OUT
XRAY
XRAY
Q4 25
$118.1M
$101.0M
Q3 25
$88.8M
$79.0M
Q2 25
$67.1M
$48.0M
Q1 25
$33.6M
$7.0M
Q4 24
$124.5M
$87.0M
Q3 24
$73.1M
$141.0M
Q2 24
$71.0M
$208.0M
Q1 24
$30.6M
$25.0M
Free Cash Flow
OUT
OUT
XRAY
XRAY
Q4 25
$93.3M
$60.0M
Q3 25
$67.7M
$40.0M
Q2 25
$41.4M
$16.0M
Q1 25
$16.4M
$-12.0M
Q4 24
$106.3M
$36.0M
Q3 24
$55.5M
$98.0M
Q2 24
$47.1M
$156.0M
Q1 24
$12.2M
$-9.0M
FCF Margin
OUT
OUT
XRAY
XRAY
Q4 25
18.2%
6.2%
Q3 25
14.5%
4.4%
Q2 25
9.0%
1.7%
Q1 25
4.2%
-1.4%
Q4 24
21.6%
4.0%
Q3 24
12.3%
10.3%
Q2 24
9.9%
15.9%
Q1 24
3.0%
-0.9%
Capex Intensity
OUT
OUT
XRAY
XRAY
Q4 25
4.8%
4.3%
Q3 25
4.5%
4.3%
Q2 25
5.6%
3.4%
Q1 25
4.4%
2.2%
Q4 24
3.7%
5.6%
Q3 24
3.9%
4.5%
Q2 24
5.0%
5.3%
Q1 24
4.5%
3.6%
Cash Conversion
OUT
OUT
XRAY
XRAY
Q4 25
1.22×
Q3 25
1.73×
Q2 25
3.44×
Q1 25
0.35×
Q4 24
1.68×
Q3 24
2.11×
Q2 24
0.40×
Q1 24
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

OUT
OUT

Static Displays$236.3M46%
Other$134.8M26%
Digital Displays$125.3M24%
Other Revenues$1.9M0%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons